a month ago
PHVS
AnalystsDebjit ChattopadhyayDebjit Chattopadhyay's Stock Forecasts
AnalystsDebjit Chattopadhyay
Sectors:
Industries:
Analyst Ranking
Top 10%
#534 out of 5507 analysts
Average Return
+14.02%
Win Rate
56%68 out of 121
Risk vs Reward
Poor
Good
Debjit Chattopadhyay's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | +328.57% | $10.57 | $45.30 | 2025-02-25 - 2026-02-24 | Strong Buy |
Maze Therapeutics IncMAZE | +180.14% | $10.37 | $29.05 | 2025-04-02 - 2026-04-01 | Strong Buy |
Ionis Pharmaceuticals IncIONS | +162.24% | $28.52 | $74.79 | 2025-04-03 - 2026-04-02 | Strong Buy |
Jounce Therapeutics IncJNCE | +158.50% | $4.94 | $12.77 | 2020-03-02 - 2021-03-02 | Buy |
Rezolute IncRZLT | +144.44% | $1.80 | $4.40 | 2025-12-12 - 2026-09-08 | Strong Buy |
Debjit Chattopadhyay Analyst Color
Get additional color on Debjit Chattopadhyay's coverage of popular stocks
a month ago
NGNE
2 months ago
EWTX
3 months ago
RZLT
6 months ago
MAZE
6 months ago
KRYS
7 months ago
NAMS
7 months ago
PEPG
10 months ago
CNTA
a year ago
QURE
a year ago
IONS
a year ago
MAZE
3 years ago
DYN
3 years ago
KRYS
Debjit Chattopadhyay's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Scribe Therapeutics IncSCTX | 1 | Strong Buy | $50.00 | +59.54% | Initiates Coverage On | 23 days ago |
Spruce Biosciences IncSPRB | 2 | Strong Buy | $104.00 | +76.00% | Maintains | 23 days ago |
Pharvaris NvPHVS | 2 | Strong Buy | $40.00 | +5.71% | Maintains | a month ago |
Neurogene IncNGNE | 1 | Strong Buy | $81.00 | +112.43% | Maintains | a month ago |
Ultragenyx Pharmaceutical IncRARE | 6 | Strong Buy | $35.00 | +135.22% | Maintains | a month ago |
Edgewise Therapeutics IncEWTX | 1 | Strong Buy | $51.00 | +16.39% | Maintains | 2 months ago |
Rezolute IncRZLT | 5 | Strong Buy | $11.00 | +150.00% | Maintains | 3 months ago |
Entrada Therapeutics IncTRDA | 2 | Strong Buy | $17.00 | +126.06% | Maintains | 3 months ago |
Opus Genetics IncIRD | 1 | Strong Buy | $16.00 | +268.66% | Initiates Coverage On | 3 months ago |
Satellos Bioscience IncMSLE | 1 | Strong Buy | $23.00 | +150.54% | Initiates Coverage On | 4 months ago |
Centessa Pharmaceuticals PLCCNTA | 9 | Hold | N/A | N/A | Downgrades | 5 months ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $26.00 | +161.83% | Initiates Coverage On | 6 months ago |
Maze Therapeutics IncMAZE | 4 | Strong Buy | $58.00 | +119.95% | Maintains | 6 months ago |
Krystal Biotech IncKRYS | 5 | Strong Buy | $284.00 | -19.15% | Maintains | 6 months ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $86.00 | +33.07% | Maintains | 6 months ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $45.00 | +75.58% | Maintains | 7 months ago |
Pepgen IncPEPG | 3 | Strong Buy | $7.00 | +118.07% | Maintains | 7 months ago |
Sarepta Therapeutics IncSRPT | 7 | Strong Buy | $19.00 | -9.26% | Maintains | 10 months ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $30.00 | +530.25% | Initiates Coverage On | a year ago |
Uniqure NvQURE | 6 | Strong Buy | $95.00 | +107.97% | Maintains | a year ago |
Ionis Pharmaceuticals IncIONS | 6 | Strong Buy | $92.00 | +62.23% | Maintains | a year ago |
Soleno Therapeutics IncSLNO | 5 | Strong Buy | $106.00 | N/A | Reiterates | a year ago |
Passage Bio IncPASG | 3 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Intellia Therapeutics IncNTLA | 3 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 6 | Strong Buy | $546.00 | N/A | Maintains | a year ago |
Dyne Therapeutics IncDYN | 5 | Strong Buy | $50.00 | N/A | Reiterates | a year ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $55.00 | N/A | Maintains | a year ago |
Prime Medicine IncPRME | 3 | Strong Buy | $18.00 | N/A | Reiterates | 2 years ago |
Benitec Biopharma IncBNTC | 2 | Strong Buy | $17.00 | N/A | Reiterates | 2 years ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 1 | Hold | N/A | N/A | Assumes | 2 years ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Allogene Therapeutics IncALLO | 1 | Buy | $29.00 | N/A | Maintains | 4 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Tourmaline Bio IncTRML | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Strong Buy | $255.00 | N/A | Initiates Coverage On | 5 years ago |
Lakefront Biotherapeutics NvLKFT | 3 | Hold | $123.00 | N/A | Downgrades | 6 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Tectonic Therapeutic IncTECX | 3 | Hold | $156.00 | N/A | Downgrades | 6 years ago |
Zymeworks IncZYME | 1 | Buy | $60.00 | N/A | Reiterates | 7 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $10.00 | N/A | Reiterates | 7 years ago |
Wave Life Sciences IncWVE | 1 | Buy | $20.00 | N/A | Maintains | 7 years ago |
Immunogen IncIMGN | 2 | Hold | $3.50 | N/A | Downgrades | 8 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $33.00 | N/A | Maintains | 8 years ago |
Global Blood Therapeutics IncGBT | 4 | Buy | $125.00 | N/A | Maintains | 8 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.